WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics targeting genetically defined oncology and inherited rare diseases, today announced that Douglas M. Fambrough, Ph.D., President and CEO, will present at two upcoming conferences, including the Stifel 2014 Healthcare Conference and the Jefferies 2014 Global London Healthcare Conference.
Help employers find you! Check out all the jobs and post your resume.
